Dernières nouvelles pour Accolade (NASDAQ:ACCD) Stock

Accolade

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Accolade Inc

BMO Capital analyst John Gibson downgrades Source Energy Services (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SHLE#TSX">SHLE</a>) from Outperform to Market Perform and lowers the price target from C$20 to C$14.

News

Downgrades

Price Target

Analyst Ratings

TSX:SHLE

BMO Capital Downgrades Source Energy Services to Market Perform, Lowers Price Target to C$14

RBC Capital analyst Brian Abrahams maintains Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Outperform and raises the price target from $181 to $182.

SRPT

RBC Capital Maintains Outperform on Sarepta Therapeutics, Raises Price Target to $182

BMO Capital analyst Phillip Jungwirth downgrades PBF Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>) from Outperform to Market Perform and lowers the price target from $42 to $35.

BMO Capital Downgrades PBF Energy to Market Perform, Lowers Price Target to $35

Macro Economic Events

Legal

Economics

U.S. Supreme Court Declines To Pause Environmental Protection Agency Methane Emissions Rule Challenged By States And Industry Groups

Rosenblatt analyst Steve Frankel maintains Imax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IMAX#NYSE">IMAX</a>) with a Buy and maintains $28 price target.

IMAX

Rosenblatt Maintains Buy on Imax, Maintains $28 Price Target

Rosenblatt analyst Catharine Trebnick maintains Zoom Video Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) with a Buy and maintains $78 price target.

Rosenblatt Maintains Buy on Zoom Video Comms, Maintains $78 Price Target

RBC Capital analyst Brian Abrahams downgrades Sage Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) from Sector Perform to Underperform and lowers the price target from $10 to $4.

SAGE

RBC Capital Downgrades Sage Therapeutics to Underperform, Lowers Price Target to $4

By <a href="https://roboforex.com/beginners/analytics/forex-forecast/?utm_source=benzinga.com&amp;utm_medium=pr&amp;utm_campaign=rf_en_external_article_04102024&amp;utm_content=analysis&amp;utm_term=forecast">RoboForex Analytical Department</a>
The EUR/USD pair has descended to 1.1027, marking its lowest point in three weeks. The drop reflects market anticipation that the European Central Bank (ECB) will continue to ease monetary policy aggressively, spurred by sluggish economic growth and inflation rates falling below the ECB&rsquo;s 2% target in the Eurozone.
Recent data revealed that the Eurozone&rsquo;s annual Consumer Price Index decreased to 1.8% in September, the lowest since April 2021 and below the forecasted 1.9%. Moreover, core inflation dipped to 2.7% year-on-year from 2.8%, contrary to expectations of remaining steady. These weaker-than-expected inflation figures have reinforced the likelihood of a rate cut at the upcoming ECB meeting in October, which would mark the third reduction in borrowing costs this year. The market currently places a 95% probability on a 25-basis-point cut.
Robust statistics from the US services sector have further pressured the EUR/USD exchange rate, adding to the euro&#39;s woes.
With a significant day ahead, the focus is now on the US job market reports, including the unemployment rate, Nonfarm Payrolls (NFP), and average wages, which could further influence the pair&rsquo;s movements.
<h3>EUR/USD Technical Analysis</h3>
<h2><a href="https://www.benzinga.com/files/u117641/eurusdh4_66.png"><img alt="" src="https://www.benzinga.com/files/u117641/eurusdh4_66.png" style="height:275px; width:624px" /></a></h2>
The EUR/USD pair recently completed a downward wave to 1.1008, followed by a corrective rise to 1.1039. Today, the expectation is for a decline to 1.0982. After reaching this target, a potential corrective movement to 1.1066 may occur. Following this correction, another downward wave to 1.0966 is anticipated. The MACD indicator supports this bearish outlook, with its signal line positioned below zero and trending downwards.
<a href="https://www.benzinga.com/files/u117641/eurusdh1_67.png"><img alt="" src="https://www.benzinga.com/files/u117641/eurusdh1_67.png" style="height:275px; width:624px" /></a>
On the hourly chart, the EUR/USD continues to develop its third wave of decline towards 1.0982. The pair formed a consolidation range around 1.1046 and achieved a local target at 1.1008 with a downward exit. A corrective move up to 1.1045 is expected today, which will likely be tested from below. Following this correction, a continued decline to 1.0982 is anticipated. The Stochastic oscillator corroborates this bearish scenario, with its signal line below 50 and poised to descend towards 20.
Disclaimer Any forecasts contained herein are based on the author&#39;s particular opinion. This analysis may not be treated as trading advice. RoboForex bears no responsibility for trading results based on trading recommendations and reviews contained herein.
This article is from an unpaid external contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

Technicals

Forex

Markets

Trading Ideas

General

EUR/USD Hits Three-Week Low Amid ECB Easing Expectations

Contracts

Management

STLA

UAW Says In First Strike Authorization Vote At Stellantis, UAW Members At LA Parts Center Overwhelmingly Approve Walkout If U.S. Investments Aren't Made

Whales with a lot of money to spend have taken a noticeably bearish stance on JD.com.
Looking at options history for JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) we detected 47 trades.
If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and 53% with bearish.
From the overall spotted trades, 16 are puts, for a total amount of $752,335 and 31, calls, for a total amount of $2,118,766.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $22.5 to $60.0 for JD.com during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for JD.com's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of JD.com's whale trades within a strike price range from $22.5 to $60.0 in the last 30 days. 
<h3>JD.com Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728054984_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/11/24</td>
<td>$3.85</td>
<td>$3.75</td>
<td>$3.75</td>
<td>$44.00</td>
<td>$365.7K</td>
<td>4.9K</td>
<td>3.7K</td>
</tr>
<tr>
<td>JD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$4.85</td>
<td>$4.65</td>
<td>$4.65</td>
<td>$60.00</td>
<td>$299.9K</td>
<td>4.8K</td>
<td>3</td>
</tr>
<tr>
<td>JD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$14.75</td>
<td>$14.65</td>
<td>$14.65</td>
<td>$40.00</td>
<td>$146.5K</td>
<td>5.2K</td>
<td>1.7K</td>
</tr>
<tr>
<td>JD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$4.85</td>
<td>$4.6</td>
<td>$4.85</td>
<td>$37.50</td>
<td>$121.2K</td>
<td>165</td>
<td>250</td>
</tr>
<tr>
<td>JD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/04/24</td>
<td>$11.5</td>
<td>$11.4</td>
<td>$11.4</td>
<td>$35.00</td>
<td>$108.3K</td>
<td>1.7K</td>
<td>132</td>
</tr>
</tbody>
</table>

<h3>About JD.com</h3>
JD.com is a leading e-commerce platform with its 2022 China GMV being similar to Pinduoduo (GMV not reported), on our estimate, but still lower than Alibaba. it offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
In light of the recent options history for JD.com, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>JD.com's Current Market Status</h3>
<ul>
<li>With a volume of 15,218,005, the price of JD is up 4.04% at $46.4. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 40 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for JD.com, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Looking At JD.com's Recent Unusual Options Activity

Financial giants have made a conspicuous bullish move on Intel. Our analysis of options history for Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) revealed 16 unusual trades.
Delving into the details, we found 62% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $146,860, and 13 were calls, valued at $539,462.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $19.0 to $55.0 for Intel during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Intel's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Intel's significant trades, within a strike price range of $19.0 to $55.0, over the past month.
<h3>Intel 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728054979_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>INTC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$32.5</td>
<td>$32.15</td>
<td>$32.23</td>
<td>$55.00</td>
<td>$64.4K</td>
<td>107</td>
<td>20</td>
</tr>
<tr>
<td>INTC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.2</td>
<td>$2.19</td>
<td>$2.2</td>
<td>$24.00</td>
<td>$59.8K</td>
<td>14.3K</td>
<td>844</td>
</tr>
<tr>
<td>INTC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$4.55</td>
<td>$4.5</td>
<td>$4.5</td>
<td>$26.00</td>
<td>$52.2K</td>
<td>4.0K</td>
<td>601</td>
</tr>
<tr>
<td>INTC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.81</td>
<td>$1.8</td>
<td>$1.81</td>
<td>$25.00</td>
<td>$46.5K</td>
<td>36.6K</td>
<td>1.4K</td>
</tr>
<tr>
<td>INTC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$0.91</td>
<td>$0.88</td>
<td>$0.9</td>
<td>$26.00</td>
<td>$45.0K</td>
<td>11.0K</td>
<td>2.5K</td>
</tr>
</tbody>
</table>

<h3>About Intel</h3>
Intel is a leading digital chipmaker, focused on the design and manufacturing of microprocessors for the global personal computer and data center markets. Intel pioneered the x86 architecture for microprocessors and was the prime proponent of Moore's law for advances in semiconductor manufacturing. Intel remains the market share leader in central processing units in both the PC and server end markets. Intel has also been expanding into new adjacencies, such as communications infrastructure, automotive, and the Internet of Things. Further, Intel expects to leverage its chip manufacturing capabilities into an outsourced foundry model where it constructs chips for others.
Having examined the options trading patterns of Intel, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Intel</h3>
<ul>
<li>Trading volume stands at 15,996,240, with INTC's price up by 2.07%, positioned at $22.72.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 20 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intel with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

INTC

Behind the Scenes of Intel's Latest Options Trends

Whales with a lot of money to spend have taken a noticeably bearish stance on EVgo.
Looking at options history for EVgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGO#NASDAQ">EVGO</a>) we detected 15 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 53% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $160,700 and 10, calls, for a total amount of $631,892.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $4.0 to $7.0 for EVgo over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in EVgo's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to EVgo's substantial trades, within a strike price spectrum from $4.0 to $7.0 over the preceding 30 days.
<h3>EVgo Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728054974_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>EVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$2.25</td>
<td>$2.2</td>
<td>$2.2</td>
<td>$5.00</td>
<td>$109.5K</td>
<td>1.1K</td>
<td>2.1K</td>
</tr>
<tr>
<td>EVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$2.2</td>
<td>$2.1</td>
<td>$2.15</td>
<td>$5.00</td>
<td>$107.5K</td>
<td>1.1K</td>
<td>1.6K</td>
</tr>
<tr>
<td>EVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$2.1</td>
<td>$2.0</td>
<td>$2.1</td>
<td>$5.00</td>
<td>$105.0K</td>
<td>1.1K</td>
<td>601</td>
</tr>
<tr>
<td>EVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$2.7</td>
<td>$2.4</td>
<td>$2.7</td>
<td>$4.00</td>
<td>$67.5K</td>
<td>766</td>
<td>262</td>
</tr>
<tr>
<td>EVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$1.0</td>
<td>$0.9</td>
<td>$1.0</td>
<td>$6.00</td>
<td>$50.0K</td>
<td>6.6K</td>
<td>2.3K</td>
</tr>
</tbody>
</table>

<h3>About EVgo</h3>
EVgo owns and operates a public direct current fast-charging network in the us. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the us. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments and independent property owners in order to locate and deploy its EV charging infrastructure.
In light of the recent options history for EVgo, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>EVgo's Current Market Status</h3>
<ul>
<li>Trading volume stands at 16,946,232, with EVGO's price up by 8.82%, positioned at $6.88.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 33 days.</li>
</ul>
<h3>What The Experts Say On EVgo</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $5.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $5. 
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $5. 
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $5. 
&#x2A; An analyst from JP Morgan has elevated its stance to Overweight, setting a new price target at $7. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for EVgo, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

EVGO

EVgo's Options: A Look at What the Big Money is Thinking

Tradeweb Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TW#NASDAQ">TW</a>) shares are<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> trading higher on Friday.</a>
Tradeweb reported a total trading volume of $56.1 trillion for September 2024, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40747223/tradeweb-reports-record-august-2024-total-trading-volume-of-50-9-trillion-and-record-average-daily" rel="noreferrer noopener">higher </a>than $50.9 trillion in August. The average daily volume (ADV) for the month reached $2.63 trillion, compared with&nbsp;$2.21 trillion in August, marking a <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41182517/tradeweb-reports-record-september-2024-total-trading-volume-of-56-1-trillion-and-record-average-da" rel="noreferrer noopener">significant year-over-year increase of 68.3%.</a>
For the third quarter, Tradeweb reported a total trading volume of $147.5 trillion, with an ADV of $2.21 trillion, reflecting a year-over-year increase of 55.3%.
The preliminary average variable fees per million dollars of volume traded were $2.29.
Excluding the impact of the ICD acquisition, which was finalized on August 1, total ADV for September rose by 50.3% year-over-year, while total ADV for the third quarter increased by 42.7%.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/10/41185026/whats-going-on-with-cisco-systems-stock-friday" rel="noreferrer noopener">What&#8217;s Going On With Cisco Systems Stock Friday?</a>
&#8220;This was our best quarter ever with record volumes in multiple asset classes,&#8221; Tradeweb CEO Billy Hult said.
In September, the average daily volume (ADV) for U.S. government bonds rose by 59.8% year-over-year to $232.2 billion. Meanwhile, European government bond ADV increased by 16.7% year-over-year, reaching $49.5 billion.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, TW stock has gained over 60% in the past year. Investors can gain exposure to the stock via&nbsp;Neuberger Berman ETF Trust Neuberger Berman Disrupters ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBDS#NYSE">NBDS</a>) and&nbsp;Listed Funds Trust Horizon Kinetics Blockchain Development ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCDF#NYSE">BCDF</a>).
Price Action: TW shares are trading higher by 3.45% to $129.99 on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41177525/biden-praises-end-of-port-strike-highlights-importance-for-hurricane-helene-recovery-collective-barg" target="_blank" rel="noreferrer noopener">Biden Praises End Of Port Strike, Highlights Importance For Hurricane Helene Recovery: ‘Collective Bargaining Works'</a></li>
</ul>

Equities

Movers

Listed Funds Trust Horizon Kinetics Blockchain Development ETF

BCDF

Neuberger Berman ETF Trust Neuberger Berman Disrupters ETF

NBDS

Why Is Tradeweb Markets Stock Gaining Friday?

Each week,&nbsp;Benzinga's Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Read Also: <a href="https://www.benzinga.com/top-stories/24/10/41150827/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-september-2024-where-do-tesla-nvidia-apple">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?</a>
<h1 class="wp-block-heading">Here&#8217;s a look at the Benzinga Stock Whisper Index for the week of Oct. 4:</h1>
Mohawk Industries Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>): The flooring products company saw strong interest from Benzinga readers over the past week. The stock was one of the top-performing S&amp;P 500 stocks in the third quarter.
Mohawk is likely getting attention from readers as the company is tossed around as a winner in the interest rate-cutting environment and could do well no matter which candidate wins the 2024 presidential election. With the company's position in flooring, Mohawk wins from more houses being built, which could be a key catalyst coming in the next year.
Mohawk is likely to report third-quarter financial results in October. Mohawk has beaten earnings per share estimates from analysts in six straight quarters and revenue estimates from analysts in five of the past six quarters.
Mohawk shares were up 0.4% over the past five trading days as seen on the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1">Benzinga Pro chart</a> below and are up over 50% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105607/Screenshot-197.png" alt="" class="wp-image-581030" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105607/Screenshot-197.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105607/Screenshot-197-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105607/Screenshot-197-768x386.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Banner Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BANR#NASDAQ">BANR</a>): The regional bank joins the Benzinga Stock Whisper Index with increased interest from readers. 
The bank, which has the majority of its branches in Oregon, Washington, California, Idaho and Utah, is set to report third-quarter financial results on Oct. 16. The bank has beaten analysts&#8217; estimates for earnings per share in four straight quarters and analyst estimates for revenue in three straight quarters. 
Raymond James recently maintained an Outperform rating on the stock and raised the price target from $62 to $65. With the recent <a href="https://www.benzinga.com/economics/macro-economic-events/24/09/40926026/federal-reserve-delivers-bold-0-5-rate-cut-signals-further-easing-ahead">interest rate cut </a>and the potential for more later this year, bank stocks are likely in the spotlight for investors.
Banner Bank shares were down on the week and are up 10.7% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="504" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105624/Screenshot-198.png" alt="" class="wp-image-581033" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105624/Screenshot-198.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105624/Screenshot-198-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105624/Screenshot-198-768x388.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Madison Square Garden Entertainment Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGE#NYSE">MSGE</a>): The owner of the iconic Madison Square Garden sports and concert venue saw increased interest from readers during the week. 
The increased interest could be related to anticipation building for the starts of the National Hockey League (NHL) and National Basketball Association (NBA) seasons. Madison Square Garden Sports Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>) owns the New York Rangers (NHL) and New York Knicks (NBA), so the entertainment company and owner of the venue can see a strong performance with high attendance and the teams being good. 
The NHL season kicks off on Oct. 9 for the Rangers and the Knicks play their first game on Oct. 22. The Knicks have high expectations for the season with a recent trade bringing NBA superstar Karl-Anthony Towns to New York. With the trade, the Knicks now have the third best odds (+800) to win the NBA Championship for the coming season.
MSGE shares were down slightly on the week. The stock is up over 33% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105639/Screenshot-199.png" alt="" class="wp-image-581035" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105639/Screenshot-199.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105639/Screenshot-199-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105639/Screenshot-199-768x387.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Schlumberger NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>): The oil stock was one of <a href="https://www.benzinga.com/news/24/10/41143156/oil-prices-spike-energy-stocks-jump-after-irans-missile-attack-on-israel-what-investors-need-to-know">many in the sector</a> that saw a boost in share price and interest due to increasing tension in the Middle East with<a href="https://www.benzinga.com/news/global/24/10/41126038/iran-attacks-israel-with-missiles-middle-east-tensions-escalates-s-p-500-stocks-bitcoin-fall-as-oil"> Iran launching a missile attack</a> against Israel. Increased attacks could hurt oil supplies and also see sanctions that could increase the price of oil. 
Schlumberger reports third-quarter financial results on Oct. 18, which could create further optimism for the stock. The company has beaten analyst earnings per share estimates in more than 10 straight quarters. The company has beaten revenue estimates from analysts in three straight quarters and eight of the past 10 quarters.
Schlumberger shares were up more than 7% in the last five trading days. Even with the recent move, the stock is down around 13% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105656/Screenshot-200.png" alt="" class="wp-image-581037" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105656/Screenshot-200.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105656/Screenshot-200-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105656/Screenshot-200-768x386.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Tompkins Financial Corp (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TMP#AMEX">TMP</a>): The community bank, financial advisor and insurance agency company may not be a household name, but the stock is seeing increased attention from investors ahead of a third-quarter earnings report expected in October. Like other banks, Tompkins could benefit from interest rate cuts. 
Keefe, Bruyette &amp; Woods recently upgraded the stock from Market Perform to Outperform and increased the price target from $59 to $68.
Tompkins Financial stock was up 2% on the week and shares are trading relatively flat year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="993" height="504" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105714/Screenshot-201.png" alt="" class="wp-image-581038" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105714/Screenshot-201.png 993w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105714/Screenshot-201-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105714/Screenshot-201-768x390.png 768w" sizes="(max-width: 993px) 100vw, 993px" /></a></figure>
Stay tuned for next week's report, and follow Benzinga Pro for all the latest headlines and&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/09/40752686/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">September 6</a></li>
<li><a href="https://www.benzinga.com/top-stories/24/09/40855829/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">September 13</a></li>
<li><a href="https://www.benzinga.com/exclusives/24/09/40962321/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">September 20</a></li>
<li><a href="https://www.benzinga.com/top-stories/24/09/41072065/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">September 27 </a></li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/09/40928301/interest-rates-in-free-fall-what-it-means-for-mortgages-credit-cards-and-your-wallet-a" target="_blank" rel="noreferrer noopener">Interest Rates In Free-Fall: What It Means For Mortgages, Credit Cards And Your Wallet As The Federal Reserve Springs Into Action For First Time In 4 Years</a></li>
</ul>

Entertainment

Commodities

Sports

Exclusives

BANR

MSGE

MSGS

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

EF Hutton analyst Jason Kolbert maintains Trevi Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVI#NASDAQ">TRVI</a>) with a Buy and maintains $21 price target.

TRVI

EF Hutton Maintains Buy on Trevi Therapeutics, Maintains $21 Price Target

American Airlines Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) shares are trading higher by 6.50% to $11.53 during Friday&#8217;s session amid a report that Spirit Airlines is <a href="https://www.benzinga.com/news/24/10/41182466/spirit-airlines-drops-over-40-amid-bankruptcy-discussions">engaging in bankruptcy talks</a> with bondholders, sending ripples through the airline industry. Spirit&#8217;s stock plummeted more than 40% in pre-market trading, signaling deep financial troubles for the budget carrier.
This development comes as Spirit struggles to manage a $3.3 billion debt load, including over $1.1 billion in secured bonds maturing imminently, while facing the possibility of a Chapter 11 bankruptcy filing.
Why This Matters: For American Airlines, Spirit&#8217;s potential collapse presents a significant opportunity in several key areas. First and foremost, Spirit&#8217;s financial woes could lead to a reduced presence in the budget airline market. This would provide legacy carriers like American Airlines the chance to capture market share, especially among budget-conscious travelers who may now look to competitors for affordable flight options.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41184080/us-economy-adds-254-000-new-jobs-in-september-smashes-expectations-unemployment-f">U.S. Economy Adds 254,000 New Jobs In September, Smashes Expectations: Unemployment Falls, Wages Increase</a>
Furthermore, Spirit&#8217;s recent challenges—including cutting capacity by nearly 20% in the fourth quarter due to supply chain issues like the recall of Pratt &amp; Whitney engines—means that there could be fewer seats available in the market overall. 
This could lead to increased demand for flights from American Airlines, which would allow the company to adjust its pricing and potentially boost revenue on key domestic routes.
What Else: Additionally, with Spirit under financial strain, American Airlines could benefit from less competition in certain markets where Spirit has been a low-cost disruptor. The potential reduction in low-cost options for travelers might allow American Airlines to attract more price-sensitive customers who are now left with fewer choices. 
Spirit's struggles might also prompt cost-cutting competitors like JetBlue to realign their strategies, further solidifying American&#8217;s dominant position in certain U.S. markets.
Moreover, with Spirit cutting capacity and facing operational challenges due to grounded planes and possible pilot furloughs, there is a possibility that American Airlines could absorb displaced travelers. 
In the short term, this could result in increased bookings and higher load factors for American's flights, especially as travelers prioritize reliability during times of uncertainty.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41185065/s-p-500-nears-record-highs-on-hot-jobs-data-dollar-treasury-yields-surge-as-aggre">S&amp;P 500 Nears Record Highs On Hot Jobs Data: Dollar, Treasury Yields Surge As Aggressive Interest Rate Cut Hopes Fade</a>
<h2 class="wp-block-heading">How To Buy AAL Stock</h2>
By now you're likely curious about how to participate in the market for American Airlines &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the the case of American Airlines, which is trading at $11.77 as of publishing time, $100 would buy you 8.5 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, AAL has a 52-week high of $16.15 and a 52-week low of $9.07.

American Airlines Stock Is Up 6.5% Today: What's Going On?

RBC Capital analyst Brian Abrahams maintains Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) with a Outperform and raises the price target from $1252 to $1260.

REGN

RBC Capital Maintains Outperform on Regeneron Pharmaceuticals, Raises Price Target to $1260

WIIM

M&T Bank shares are trading higher after Wolfe Research upgraded the stock from Peer Perform to Outperform and announced a $210 price target.

DOCN

DigitalOcean shares are trading higher after Canaccord Genuity maintained a Buy rating and raised its price target from $42 to $48.

U.S. HHS Official Says BARDA Awarding Additional $72M In New Grants For Bird Flu Vaccine Manufacturing; Bird Flu Vaccine Grants Awarded To Sanofi, GSK, And CSL; CDC Has Confirmed Two New Human Cases Of Bird Flu In California; 2 California Dairy Farm Workers That Contracted Bird Flu Had Conjunctivitis, Neither Reported Respiratory Symptoms; California Is Conducting Symptom Monitoring Of Other Exposed Workers On The Dairy Farms; 56 Dairy Farms In California Have Reported Bird Flu Infections

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Myomo (MYO – Research Report) and Accolade (ACCD – R...

Analysts Offer Insights on Healthcare Companies: Myomo (MYO) and Accolade (ACCD)

Catalyst Watch: Disney earnings, Costco sales update, MicroStrategy split, and eyes on AI patents

Accolade gains on report of takeover interest

In a report released yesterday, Michael Cherny from Leerink Partners reiterated a Buy rating on Accolade (ACCD – Research Report), with a price tar...

Accolade's Growth and Profitability Outlook Underscored by Buy Rating

Accolade: Consider Both Short-Term Revenue Outlook And Rumored Takeover

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Harrow Health (HROW – Research Report), Accolade (AC...

Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Accolade (ACCD) and Champions Oncology (CSBR)

In a report released today, Gil Luria from D.A. Davidson maintained a Hold rating on Accolade (ACCD – Research Report). The company's shares closed...

D.A. Davidson Sticks to Their Hold Rating for Accolade (ACCD)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Accolade (ACCD – Research Report) and Larimar Ther...

Analysts Conflicted on These Healthcare Names: Accolade (ACCD) and Larimar Therapeutics (LRMR)

Accolade (ACCD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Richard Close from Cana...

Buy Rating Affirmed for Accolade Amid Strong Performance and Market Recovery Potential

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Accolade (ACCD – Research Report) and Satellos Bioscience (MSCLF ...

Analysts' Opinions Are Mixed on These Healthcare Stocks: Accolade (ACCD) and Satellos Bioscience (OtherMSCLF)

ABNB

ACCD

AMCX

AMGN

ANET

APTV

CCOI

CELH

CHKP

CLOV

COST

CPNG

CPRI

CRWD

CSBR

DAVE

DDOG

ENVA

EXPE

FIVE

FSLY

FTNT

FWRD

GILD

GOOG

HESM

HROW

HTLF

ISPO

LIDR

LRMR

LUMN

MNST

MSCLF

MSFT

MSTR

PARAA

SHOP

SILK

SKYW

SMCI

THRM

TTWO

UBER

UMBF

VZIO

WKME

WULF

Penny Stocks

Small Cap

Press Releases

ACCD Investors Have the Opportunity to Join Accolade, Inc. Securities Fraud Investigation with The Schall Law Firm

Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Accolade To Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

First-of-its-kind Healthcare Innovation Provides Synchronized, Customized Whole-Health Strategies

Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Earnings

Accolade to Announce Fiscal Second Quarter 2025 Financial Results

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

Biodesix

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Concord Medical Services

Cross Country Healthcare, Inc. - Common Stock

Cross Country Healthcare

Castle Biosciences

DocGo

Enhabit

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Euda Health Holdings Limited - Ordinary Shares

EUDA Health Holdings

Fulgent Genetics

InnovAge Holding

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

23andMe Holding

ModivCare

National Research Corporation - Common Stock

National Research

Nutex Health

OPKO Health

Performant Financial Corporation - Common Stock

Performant Finl

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Pennant Gr

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

SHL Telemedicine Ltd - American Depositary Shares

SHL Telemedicine

Talkspace

Guggenheim

Stifel

Truist Securities

Morgan Stanley

Barclays

Comments

Accolade

Actualités

Dernières nouvelles pour Accolade (NASDAQ:ACCD) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL